|
1
|
Kinnula VL, Fattman CL, Tan RJ and Oury
TD: Oxidative stress in pulmonary fibrosis: a possible role for
redox modulatory therapy. Am J Respir Crit Care Med. 172:417–422.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Murin S, Smith BK and Matthay R: Other
smoking affected pulmonary diseases. Clin Chest Med. 21:121–137.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cisneros-Lira J, Gaxiola M, Ramos C,
Selman M and Pardo A: Cigarette smoke exposure potentiates
bleomycin-induced lung fibrosis in guinea pigs. Am J Physiol Lung
Cell Mol Physiol. 285:L949–L956. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vlalov SL, Gabbiani G and Kapanci Y: Rat
alveolar myofibro-blasts acquire alpha-smooth muscle actin
expression during bleomycin-induced pulmonary fibrosis. Am J
Pathol. 143:1754–1765. 1993.
|
|
5
|
Wasowicz W, Nève S and Peretz A: Optimized
steps in fluorometric determination of thiobarbituric acid-reactive
substances in serum: importance of extraction pH and influence of
sample preservation and storage. Clin Chem. 39:2522–2526.
1993.PubMed/NCBI
|
|
6
|
Sun Y, Oberley LW and Ying L: A simple
method for clinical assay of superoxide dismutase. Clin Chem.
34:497–500. 1988.PubMed/NCBI
|
|
7
|
Prajda N and Weber G: Malignant
transformation-linked imbalace: decreased XO activity in hepatomas.
FEBS Lett. 59:245–249. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ashcroft T, Simpson JM and Timbrell V:
Simple method of estimating severity of pulmonary fibrosis on a
numerical scale. J Clin Pathol. 41:467–470. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lower EE, Strohofer S and Baughman RP:
Bleomycin causes alveolar macrophages from cigarette smokers to
release hydrogen peroxide. Am J Med Sci. 295:193–197. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takada K, Takahashki K, Sato S and Yasui
S: Cigarette smoke modifies bleomycin-induced lung injury to
produce lung emphysema. Tohoku J Exp Med. 153:137–144. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schwartz DA, Helmers RA, Galvin JR, et al:
Determinants of survival in idiopathic pulmonary fibrosis. Am J
Respir Crit Care Med. 149:450–454. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baumgartner KB, Samet J, Stidley CA, et
al: Cigarette smoking: a risk factor for idiopathic pulmonary
fibrosis. Am J Respir Crit Care Med. 155:242–248. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
King TE, Tooze JA, Schwarz MI, Brown KR
and Cherniack RM: Predicting survival in idiopathic pulmonary
fibrosis: scoring system and survival model. Am J Respir Crit Care
Med. 164:1171–1181. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Osanai K, Takahashi K, Suwabe A, et al:
The effect of cigarette smoke on bleomycin-induced pulmonary
fibrosis in hamsters. Am Rev Respir Dis. 138:1276–1281. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johansson S, Bjermer L, Franzen L and
Henriksson R: Effects of ongoing smoking on the development of
radiation-induced pneumonitis in breast cancer and oesophagus
cancer patients. Radiother Oncol. 49:41–47. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nilsson K, Henriksson R, Cai YQ, Hellstrom
S, Hornqvist BS and Bjermer L: Effects of tobacco-smoke on
radiation-induced pneumonitis in rats. Int J Radiat Biol.
62:719–727. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jarvis MJ: Trends in sales weighted tar,
nicotine, and carbon monoxide yields of UK cigarettes. Thorax.
56:960–963. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Morse D: The role of heme oxygenase-1 in
pulmonary fibrosis. Am J Respir Cell Mol Biol. 29:S82–S86.
2003.PubMed/NCBI
|
|
19
|
Piantadosi CA: Carbon monoxide poisoning.
N Engl J Med. 347:1054–1055. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vremen HJ, Wong RJ and Stevenson DK:
Carbon monoxide in breath, blood, and other tissues. Carbon
Monoxide Toxicity. Penney DG: CRC Press; FL: pp. 19–60. 2000,
View Article : Google Scholar
|
|
21
|
Zhou Z, Song R, Fattman CL, et al: Carbon
monoxide suppresses bleomycin-induced lung fibrosis. Am J Pathol.
166:27–37. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ng CS, Wan S and Yim AP: Pulmonary
ischemia-reperfusion injury: role of apoptosis. J Eur Res.
25:356–363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu SH, Ma K, Xu B and Xu XR: Carbon
monoxide inhalation protects lung from lipopolysaccharide-induced
injury in rat. Sheng Li Xue Bao. 58:483–489. 2006.PubMed/NCBI
|
|
24
|
Brigham KL and Meyrick B: Endotoxin and
lung injury. Am Rev Respir Dis. 133:913–927. 1986.PubMed/NCBI
|
|
25
|
Otterbein LE, Mantell LL and Choi AM:
Carbon monoxide provides protection against hyperoxic lung injury.
Am J Physiol. 276:L688–L694. 1999.PubMed/NCBI
|
|
26
|
Clayton CE, Carraway MS, Suliman HB, et
al: Inhaled carbon monoxide and hyperoxic lung injury in rats. Am J
Physiol Lung Cell Mol Physiol. 281:L949–L957. 2001.PubMed/NCBI
|
|
27
|
Blom-Muilwijk MC, Vriesendorp R, Veninga
TS, et al: Pulmonary toxicity after treatment with bleomycin alone
or in combination with hyperoxia. Br J Anaesth. 60:91–97. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tryka AF, Skornik WA, Godleski JJ and
Brain JD: Potentiation of bleomycin-induced lung injury by exposure
to 70% oxygen. Am Rev Respir Dis. 126:1074–1076. 1982.PubMed/NCBI
|
|
29
|
Sleijfer S: Bleomycin-induced pneumonitis.
Chest. 120:617–624. 2001. View Article : Google Scholar
|
